Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis. - Liu, Xin Tracy; Huang, Yu; Liu, Da; Jiang, Yingxin Celia; Zhao, Min; Chung, Long Hoa; Han, Xingxing Daisy; Zhao, Yinan; Chen, Jinbiao; Coleman, Paul; Ting, Ka Ka; Tran, Collin; et al. (Journal of Translational Medicine, 2024)